RFA BPO Acne Treatment 2.5%

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: RFA BPO Acne Treatment 2.5%
Generic name: BENZOYL PEROXIDE
Manufacturer: Topiderm, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: c5053e9e-7608-45d9-9b9b-9b93210eb917
SPL ID: 62739ef1-542e-449d-aaad-c98403d7f895
Version: 1
Effective date: 2026-07-27
Source export date: 2026-10-30
Source partition: 14
Source file: https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/7f38ccf216257b076837276c278194f298b4ccda641215a8f83814b33a860b51/drug-label-0014-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 20:01:47

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		RFA BPO Acne Treatment 2.5%	openfda.brand_name
generic name		BENZOYL PEROXIDE	openfda.generic_name
manufacturer name		Topiderm, Inc.	openfda.manufacturer_name
ndc	package	51326-176-01	openfda.package_ndc
ndc	product	51326-176	openfda.product_ndc
ndc11	package	51326017601	derived:openfda.package_ndc
rxcui		200009	openfda.rxcui
spl id		62739ef1-542e-449d-aaad-c98403d7f895	id
spl set id		c5053e9e-7608-45d9-9b9b-9b93210eb917	set_id
unii		W9WZN9A0GM	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. When using this product avoid unnecessary sun exposure and use a sunscreen. Keep away from eyes, lips, and mouth. If irritation develops, discontinue use and consult a doctor. Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, consult a doctor. May bleach fabrics. Keep out of reach of children. If swallowed, seek professional assistance or contact a Poison Control Center immediately.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.